Clinical Study

Nicotine Enemas for Active Crohn's Colitis: An Open Pilot Study

Table 2

Baseline characteristics of 10 patients with Crohn’s colitis. Extent of disease: 1 = proctitis, 2 = sigmoid colon, 3 = descending colon, 4 = transverse colon, 5 = ascending colon, 6 = pancolitis, 7 = ileal, 8 = perianal. “Recent enemas” refers to any steroid or 5 aminosalicylate (5-ASA) enemas taken from 1 to 3 weeks before entry into the study. All concomitant medication doses given are the daily amounts, the only oral steroid taken was prednisolone, aza = azathioprine. CDAI = Crohn’s disease activity index.

No. Age (years) Sex Exsmoker Disease extent Duration relapse (weeks) Recent enemas 5-ASA (g) Oral steroids (mg) Aza (mg) Baseline CDAI score

141M1,2,3,4>9973
227M+11156
352F+6,7>9910150
459M+2,573.2150246
573M+6>992.410200
638M6,89167
759F+2,3,4>991.2272
879M+3,430259
927M113.0144
1062F+2,35foam2.450348